Refers to BTK making a comeback as industry
Quotes Michael Sjostrom of Pictect & Co Geneva, having
holdings in GILEAD, Vertex, and Coulter.. Companies are
completing their trial periods of important drugs and "will
make a lot of money in ther market"...
understand VRTX has 20+ drugs..